Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal deadline: Sept 25, 2023
Damon Runyon Clinical Investigator Award
This program aims to support independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity, in order to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: Sept 30, 2023
HDFCCC Diversity, Equity, Inclusion and Accessibility Mini-Grants
The HDFCCC Office of DEIA is now offering four types of mini-grants to Cancer Center faculty, staff, and trainees: (1) Administrative Support, (2) Community Building, (3) Conference Travel, and 4) Professional Development. - Deadline: Oct 2, 2023
UCSF Resource Allocation Program (RAP) Fall Cycle 2023
The UCSF Resource Allocation Program (RAP) offers a single online application process for a variety of intramural grants. Grants of interest include:- Mentored Scientist Award in Pancreas Cancer
- Global Cancer Pilot Award
- Pilot Award in Precision Imaging of Cancer and Therapy
- Pilot Award for Pancreas Cancer
- Pilot Award for Early Career Investigators and Established Investigators
- Catalyst Awards to Develop Therapeutics, Diagnostics, Medical Devices, Digital Health, and Biotools
- and many more!
- Deadline: Oct 20, 2023
UCSF Computational Cancer Research RFA
The Center for Cancer Data Science, a partnership between the Helen Diller Family Comprehensive Cancer Center and the Bakar Computational Health Sciences Institute, is requesting applications for projects in computational cancer research that harness data available in Information Commons. - Deadline: Nov 15, 2023
UCSF Prostate Cancer Program 2023 Pilot Research Awards
The UCSF Prostate Cancer Program announces a call for applications for funds for pilot projects in prostate cancer research at UCSF. All areas of prostate cancer research at UCSF, including computational, laboratory, translational, clinical, and population sciences, are eligible for awards. This is the second cycle of funding in 2023. - Deadline: rolling submissions
University of California Hematologic Malignancies Consortium (UCHMC) RFA
The University of California Hematologic Malignancies Consortium is requesting submission of proposals within two potential areas of funding.- RFP A: UCHMC funds for Junior Faculty and Trainee Competitive Seed Grants
- RFP B: UCHMC funds for Clinical Trials Support
Foundations/Other Sources
- Nomination deadline: Oct 12, 2023
2024 Wolf Prize
UCSF has been invited to submit one or more candidate(s) for the 2024 Wolf Prize. Candidates can be nominated only in Physics, Mathematics, Medicine, Agriculture, or Music. - Deadline: Oct 15, 2023
American Cancer Society Clinician Scientist Development Grant
The American Cancer Society (ACS) has issued a request for applications for its Clinician Scientist Development Grant. This grant will support full-time faculty members in becoming independent investigators as clinician scientists, and is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.- UCSF investigators, please email [email protected] to announce your intention to apply, then follow application instructions in RFP, conferring with your Grants Officer as needed.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
-
Due Sept 23: NCI Administrative Supplements to Support Cancer Disparity Collaborative Research
The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. [Eligible grants: R01, R37, U01, P01, P20, P50, U19, U54, U56, UM2, UG1, UM1.] - Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
- Supplement for your NCI grant: Apply for Administrative Supplements to Support Cancer Disparity Collaborative Research (PAR-22-114)
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
To view NCI funding opportunities, search here